Serve health professionals in hospitals around the world. We provide therapeutic solutions and essential injectable medicines to help them treat their patients under optimal conditions.
MISSION LABORATOIRE AGUETTANT VF frame at 0m5s e1690469129577
See the video

our expertise

Aguettant is a healthcare player expert in essential hospital drugs and ready-to-use medicines. Enabling the 5 rights of medication right patient, right drug, right time, right dose, right route is essential for us.
/ 2
Aires therapeutiques

Expert in hospital

& essential medicines

Established for more than a century in the Lyon region, Laboratoire Aguettant has forged an international reputation in the field of injectable drugs used in hospitals, particularly in anesthesia, resuscitation and emergency services.

See more
pret a lemploi e1690366447690

Injectable &

ready-to-use expert

Patient safety has been Aguettant's priority since its creation. Our teams are focused on the development of a range of health products adapted to the challenges of daily medical practice with, in particular, ready-to-administer injectable medicines (pre-filled syringes) to make a safer environment.

See more
photos diagnostic home page page diag

Expertise expanded

to in vitro diagnostic

Aguettant diversifies into in vitro diagnostics. Aware that therapy and diagnosis are closely linked, we mobilize our expertise within our two subsidiaries in favor of solutions dedicated to the biological monitoring of biotherapies as well as the development of medical countermeasures against CBRN (Chemical, Biological, Radiological, and Nuclear) risks.
See more

Learn more
about aguettant

/ 5
Join Aguettant


our jobs

Learn more
Discover our job openings
This site was designed and created by the agency customR in a sustainable way, with technologies to reduce its carbon impact. It produces only 0.2g of CO2 per page viewed and is powered by renewable energy. Carbon calculations were done with websitecarbon.
INT 175/00 Septembre 2023
Last update of the site : 

October 16, 2023